DK1589014T3 - Fremgangsmåde til syntese af derivater af 1,3-dihydro-2H-3-benzazepin-2-on og anvendelse heraf ved syntese af ivabradin og additionssalte heraf med en farmaceutisk acceptabel syre - Google Patents

Fremgangsmåde til syntese af derivater af 1,3-dihydro-2H-3-benzazepin-2-on og anvendelse heraf ved syntese af ivabradin og additionssalte heraf med en farmaceutisk acceptabel syre

Info

Publication number: DK1589014T3
Authority: DK; Denmark
Prior art keywords: synthesis; ivabradine; benzazepin; dihydro; derivatives
Prior art date: 2004-04-13

Application number

DK05290382T

Other languages

Danish (da)

English (en)

Inventor

Jean-Michel Lerestif

Jean-Pierre Lecouve

Daniel Brigot

Original Assignee

Servier Lab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-04-13

Filing date

2005-02-21

Publication date

2008-02-25

2005-02-21 Application filed by Servier Lab filed Critical Servier Lab

2008-02-25 Application granted granted Critical

2008-02-25 Publication of DK1589014T3 publication Critical patent/DK1589014T3/da

Links

230000015572 biosynthetic process Effects 0.000 title 2
238000003786 synthesis reaction Methods 0.000 title 2
WUYVQJOTPXVUIS-UHFFFAOYSA-N 1,3-dihydro-3-benzazepin-2-one Chemical class C1=CNC(=O)CC2=CC=CC=C21 WUYVQJOTPXVUIS-UHFFFAOYSA-N 0.000 title 1
239000002253 acid Substances 0.000 title 1
ACRHBAYQBXXRTO-OAQYLSRUSA-N ivabradine Chemical compound C1CC2=CC(OC)=C(OC)C=C2CC(=O)N1CCCN(C)C[C@H]1CC2=C1C=C(OC)C(OC)=C2 ACRHBAYQBXXRTO-OAQYLSRUSA-N 0.000 title 1
229960003825 ivabradine Drugs 0.000 title 1
238000000034 method Methods 0.000 title 1
150000003839 salts Chemical class 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/16—Benzazepines; Hydrogenated benzazepines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Vascular Medicine (AREA)
Urology & Nephrology (AREA)
Hospice & Palliative Care (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Other In-Based Heterocyclic Compounds (AREA)
Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

DK05290382T 2004-04-13 2005-02-21 Fremgangsmåde til syntese af derivater af 1,3-dihydro-2H-3-benzazepin-2-on og anvendelse heraf ved syntese af ivabradin og additionssalte heraf med en farmaceutisk acceptabel syre DK1589014T3 (da)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR0403829A FR2868776B1 (fr)	2004-04-13	2004-04-13	Nouveau procede de synthese de derives de la 1,3-dihydro- 2h-3-benzazepin-2-one, et application a la synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable

Publications (1)

Publication Number	Publication Date
DK1589014T3 true DK1589014T3 (da)	2008-02-25

Family

ID=34941960

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK05290382T DK1589014T3 (da)	2004-04-13	2005-02-21	Fremgangsmåde til syntese af derivater af 1,3-dihydro-2H-3-benzazepin-2-on og anvendelse heraf ved syntese af ivabradin og additionssalte heraf med en farmaceutisk acceptabel syre

Country Status (32)

Country	Link
US (1)	US7074920B2 (sr)
EP (1)	EP1589014B1 (sr)
JP (2)	JP4511970B2 (sr)
KR (1)	KR100636500B1 (sr)
CN (1)	CN1332951C (sr)
AR (1)	AR047686A1 (sr)
AT (1)	ATE375339T1 (sr)
AU (1)	AU2005200860B2 (sr)
BR (1)	BRPI0500478B8 (sr)
CA (1)	CA2496721C (sr)
CY (1)	CY1107101T1 (sr)
DE (1)	DE602005002776T2 (sr)
DK (1)	DK1589014T3 (sr)
EA (1)	EA007744B1 (sr)
ES (1)	ES2294652T3 (sr)
FR (1)	FR2868776B1 (sr)
GE (1)	GEP20074137B (sr)
HR (1)	HRP20070503T3 (sr)
MA (1)	MA27599A1 (sr)
ME (1)	ME01402B (sr)
MX (1)	MXPA05003695A (sr)
MY (1)	MY141223A (sr)
NO (1)	NO329438B1 (sr)
NZ (1)	NZ538327A (sr)
PL (1)	PL1589014T3 (sr)
PT (1)	PT1589014E (sr)
RS (1)	RS50546B (sr)
SG (1)	SG116573A1 (sr)
SI (1)	SI1589014T1 (sr)
UA (1)	UA81772C2 (sr)
WO (1)	WO2005111026A1 (sr)
ZA (1)	ZA200501467B (sr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2868776B1 (fr) *	2004-04-13	2008-04-18	Servier Lab	Nouveau procede de synthese de derives de la 1,3-dihydro- 2h-3-benzazepin-2-one, et application a la synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
FR2868777B1 (fr) *	2004-04-13	2006-05-26	Servier Lab	Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
EP2162438A4 (en)	2007-05-30	2011-07-06	Ind Swift Lab Ltd	PROCESS FOR THE PREPARATION OF IVABRADINE HYDROCHLORIDE AND CORRESPONDING POLYMORPHIDE
ES2402765T3 (es)	2008-12-22	2013-05-08	Krka, D.D., Novo Mesto	Procedimiento de preparación de ivabradina
EP2534135A2 (en)	2010-02-12	2012-12-19	KRKA, D.D., Novo Mesto	Novel forms of ivabradine hydrochloride
FR2956401B1 (fr) *	2010-02-17	2012-02-03	Servier Lab	Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
FR2984320B1 (fr) *	2011-12-20	2013-11-29	Servier Lab	Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3119874A1 (de) *	1981-05-19	1982-12-09	Dr. Karl Thomae Gmbh, 7950 Biberach	"benzazepinderivate, ihre herstellung und ihre verwendung als arzneimittel"
US4490369A (en) *	1981-05-19	1984-12-25	Dr. Karl Thomae Gesellschaft Mit Beschrankter Haftung	Benzazepine derivatives, their pharmaceutical compositions and method of use
DE3242599A1 (de) *	1982-11-18	1984-05-24	Dr. Karl Thomae Gmbh, 7950 Biberach	Neue benzazepinderivate, ihre herstellung und ihre verwendung als arzneimittel
DE3418270A1 (de) *	1984-05-17	1985-11-21	Dr. Karl Thomae Gmbh, 7950 Biberach	Neue aminotetralinderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
DE3519735A1 (de) *	1985-06-01	1986-12-04	Dr. Karl Thomae Gmbh, 7950 Biberach	Neue heteroaromatische aminderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
EP0204349A3 (de) *	1985-06-01	1990-01-03	Dr. Karl Thomae GmbH	Neue heteroaromatische Aminderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
DE3717561A1 (de) *	1987-05-25	1988-12-08	Thomae Gmbh Dr K	Indol-, isochinolin- und benzazepinderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
JP2568416B2 (ja) *	1986-11-04	1997-01-08	大塚製薬株式会社	ヒドロフルオレン誘導体
JPH0495078A (ja) *	1990-08-08	1992-03-27	Nippon Shoji Kk	ピリミドン誘導体の製造法、そのための中間体
FR2681862B1 (fr) *	1991-09-27	1993-11-12	Adir Cie	Nouvelles (benzocycloalkyl)alkylamines, leur procede de preparation, et les compositions pharmaceutiques qui les contiennent.
TW279860B (sr) *	1993-11-12	1996-07-01	Ciba Geigy Ag
FR2868776B1 (fr) *	2004-04-13	2008-04-18	Servier Lab	Nouveau procede de synthese de derives de la 1,3-dihydro- 2h-3-benzazepin-2-one, et application a la synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
FR2868777B1 (fr) *	2004-04-13	2006-05-26	Servier Lab	Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable

2004
- 2004-04-13 FR FR0403829A patent/FR2868776B1/fr not_active Expired - Fee Related
2005
- 2005-02-07 CA CA2496721A patent/CA2496721C/fr not_active Expired - Lifetime
- 2005-02-14 US US11/057,491 patent/US7074920B2/en not_active Expired - Lifetime
- 2005-02-15 SG SG200500769A patent/SG116573A1/en unknown
- 2005-02-17 BR BRPI0500478A patent/BRPI0500478B8/pt not_active IP Right Cessation
- 2005-02-18 AR ARP050100587A patent/AR047686A1/es active IP Right Grant
- 2005-02-18 JP JP2005041811A patent/JP4511970B2/ja not_active Expired - Lifetime
- 2005-02-18 MY MYPI20050622A patent/MY141223A/en unknown
- 2005-02-18 UA UAA200501523A patent/UA81772C2/uk unknown
- 2005-02-18 CN CNB2005100542097A patent/CN1332951C/zh not_active Expired - Lifetime
- 2005-02-18 ZA ZA2005/01467A patent/ZA200501467B/en unknown
- 2005-02-18 AU AU2005200860A patent/AU2005200860B2/en not_active Expired
- 2005-02-18 NO NO20050885A patent/NO329438B1/no unknown
- 2005-02-18 NZ NZ538327A patent/NZ538327A/en not_active IP Right Cessation
- 2005-02-18 GE GEAP8648A patent/GEP20074137B/en unknown
- 2005-02-18 MA MA28113A patent/MA27599A1/fr unknown
- 2005-02-19 KR KR1020050013871A patent/KR100636500B1/ko not_active Expired - Lifetime
- 2005-02-21 PL PL05290382T patent/PL1589014T3/pl unknown
- 2005-02-21 EA EA200500237A patent/EA007744B1/ru unknown
- 2005-02-21 RS RSP-2007/0493A patent/RS50546B/sr unknown
- 2005-02-21 ME MEP-2007-493A patent/ME01402B/me unknown
- 2005-02-21 ES ES05290382T patent/ES2294652T3/es not_active Expired - Lifetime
- 2005-02-21 DK DK05290382T patent/DK1589014T3/da active
- 2005-02-21 WO PCT/FR2005/000395 patent/WO2005111026A1/fr not_active Ceased
- 2005-02-21 SI SI200530088T patent/SI1589014T1/sl unknown
- 2005-02-21 PT PT05290382T patent/PT1589014E/pt unknown
- 2005-02-21 AT AT05290382T patent/ATE375339T1/de active
- 2005-02-21 DE DE602005002776T patent/DE602005002776T2/de not_active Expired - Lifetime
- 2005-02-21 EP EP05290382A patent/EP1589014B1/fr not_active Expired - Lifetime
- 2005-04-07 MX MXPA05003695A patent/MXPA05003695A/es active IP Right Grant
2007
- 2007-10-29 HR HR20070503T patent/HRP20070503T3/xx unknown
- 2007-12-19 CY CY20071101612T patent/CY1107101T1/el unknown
2009
- 2009-09-25 JP JP2009220282A patent/JP2010043096A/ja active Pending

Also Published As

Publication number	Publication date
NZ538327A (en)	2005-11-25
EP1589014A1 (fr)	2005-10-26
FR2868776B1 (fr)	2008-04-18
MA27599A1 (fr)	2005-11-01
CY1107101T1 (el)	2012-10-24
KR100636500B1 (ko)	2006-10-18
KR20060042120A (ko)	2006-05-12
UA81772C2 (uk)	2008-02-11
JP4511970B2 (ja)	2010-07-28
MY141223A (en)	2010-03-31
EA007744B1 (ru)	2006-12-29
PT1589014E (pt)	2007-12-13
JP2005298479A (ja)	2005-10-27
RS50546B (sr)	2010-05-07
AU2005200860A1 (en)	2005-10-27
CA2496721C (fr)	2010-09-07
WO2005111026A1 (fr)	2005-11-24
US20050227962A1 (en)	2005-10-13
ES2294652T3 (es)	2008-04-01
PL1589014T3 (pl)	2008-01-31
ME01402B (me)	2010-05-07
AR047686A1 (es)	2006-02-01
HK1079776A1 (en)	2006-04-13
CA2496721A1 (fr)	2005-10-13
FR2868776A1 (fr)	2005-10-14
BRPI0500478A (pt)	2005-11-16
DE602005002776D1 (de)	2007-11-22
EP1589014B1 (fr)	2007-10-10
NO329438B1 (no)	2010-10-18
AU2005200860B2 (en)	2010-08-05
BRPI0500478B1 (pt)	2019-04-02
DE602005002776T2 (de)	2008-08-28
SG116573A1 (en)	2005-11-28
GEP20074137B (en)	2007-06-25
ZA200501467B (en)	2005-11-30
NO20050885L (no)	2005-10-14
CN1683342A (zh)	2005-10-19
MXPA05003695A (es)	2006-01-24
HRP20070503T3 (en)	2007-12-31
US7074920B2 (en)	2006-07-11
NO20050885D0 (no)	2005-02-18
EA200500237A1 (ru)	2005-10-27
ATE375339T1 (de)	2007-10-15
BRPI0500478B8 (pt)	2021-05-25
SI1589014T1 (sl)	2008-02-29
JP2010043096A (ja)	2010-02-25
CN1332951C (zh)	2007-08-22

Publication	Publication Date	Title
DK1589005T3 (da)	2007-07-30	Fremgangsmåde til syntese af ivabradin og additionssalte heraf med en farmaceutisk acceptabel syre
NO20050883D0 (no)	2005-02-18	Ny fremgangsmate for syntesen (IS)-4,5-dimetoksy-1-(metylaminometyl)-benzocyklobutan og addisjonssalter derav, og anvendelse i syntesen av ivabradin og addisjonssalter derav med en farmasoytisk akseptabel syre
NO2022022I1 (no)	2022-06-09	Fedratinib, or a pharmaceutically acceptable salt thereof, or a pharmaceutically acceptable hydrate thereof, in particular fedratinib dihydrochloride monohydrate
DK2135861T4 (da)	2021-03-22	Fremgangsmåde til syntese af 7,8-dimethoxy-1,3-dihydro-2H-3-benzazepin-2-on og dets anvendelse ved syntese af ivabradin såvel som dets additionssalte med en farmaceutisk acceptabel syre
IL192241A (en)	2014-01-30	A process for making 4 - (benzimidazolylmethylamino) - benzamides and their salts
DK2202225T3 (da)	2013-02-11	Ny fremgangsmåde til syntese af ivabradin og additionssalte heraf med en farmaceutisk acceptabel syre
IL179424A0 (en)	2007-05-15	Substituted oxazole -benzoisothiazole dioxide derivatives, process for their preparation and their use
IL193155A0 (en)	2009-02-11	Tetrahydronaphthaline derivatives, methods for the production and use thereof as anti-inflammatory agents
DK1614687T3 (da)	2010-03-29	Fremgangsmåde til fremstilling af 1,3,4,5-tetrahydro-2H-3-benzazepin-2-onderivater og deres anvendelse ved syntese af ivabradin og farmaceutisk acceptable salte deraf
DE602005011326D1 (de)	2009-01-08	Feste pharmazeutische zusammensetzung mit donepezilhydrochlorid
PL1876169T3 (pl)	2016-06-30	Pochodne amin n-acylowych i aminokwasów zawierające fenyl, sposoby ich wytwarzania, kompozycje farmaceutyczne i ich zastosowanie
DK1589014T3 (da)	2008-02-25	Fremgangsmåde til syntese af derivater af 1,3-dihydro-2H-3-benzazepin-2-on og anvendelse heraf ved syntese af ivabradin og additionssalte heraf med en farmaceutisk acceptabel syre
DK1420028T3 (da)	2007-06-18	Fremgangsmåde til syntese af perindopril og farmaceutisk acceptable salte heraf
WO2007144699A3 (en)	2010-10-21	Process for the preparation of alfuzosin
SI1753720T1 (sl)	2014-08-29	Postopek za pripravo perindoprila in njegovih soli
DK1380591T3 (da)	2006-01-23	Fremgangsmåde til syntese af perindopril og farmaceutiske acceptable salte heraf
IL188260A0 (en)	2008-08-07	6-oxazol-4-ylmethoxy-alkoxymethyl substituted benzoic acid derivatives forming ppar ligands, methods for production and the use thereof in the form of drugs
ATE441643T1 (de)	2009-09-15	N-ä(4,5-diphenylpyrimidin-2- yl)methylüaminderivate, deren herstellung und deren therapeutische verwendung
DK1403275T3 (da)	2005-12-05	Fremgangsmåde til syntese af perindopril og farmaceutisk acceptable salte heraf
IL182125A0 (en)	2007-07-24	Optically active 4,4-di-substituted oxazolidine derivatives and processes for the preparation thereof
DK1367063T3 (da)	2006-12-27	Fremgangsmåde til syntese af perindopril og farmaceutisk acceptable salte heraf
GB0807094D0 (en)	2008-05-21	4,4-dimethylpiperidine-2, 6-dione derivatives for use in the treatment of hypertension
SG117528A1 (en)	2005-12-29	New process for the synthesis of (1S)-4,5-dimethoxy-1-(methylaminomethyl)-benzocyclobutane and addition salts thereof, and application in the synthesis of ivabradine and addition salts thereof, with
WO2008005955A8 (en)	2008-07-03	Synthesis of heterocyclic compounds